GlassScriptPhysician profile
Andrea Littlefield
NPI 1801417613
$2,840.33
in general payments reported to CMS, 2019-2025
22 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 90% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,014 · 2024: $772 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,840.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,840.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $461.12 | 2023-2025 | Erleada, Carvykti, Rybrevant |
| C. R. Bard, INC. & Subsidiaries | $397.81 | 2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter, Purewick Female External Catheter |
| Sumitomo Pharma America, INC. | $366.47 | 2023-2025 | Gemtesa |
| Myriad Genetic Laboratories, INC. | $203.60 | 2023-2025 | Prolaris |
| Abbvie INC. | $192.34 | 2024-2025 | |
| Urogen Pharma, INC. | $189.66 | 2024-2025 | |
| Pfizer INC. | $186.51 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $180.78 | 2023-2025 | |
| Tempus Ai, INC | $120.47 | 2024 | Xt Cdx |
| Antares Pharma, INC. | $97.41 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Teleflex LLC | $74.07 | 2024-2025 | Urolift |
| Astellas Pharma US INC | $63.80 | 2023-2024 | Xtandi |
| Telix Pharmaceuticals | $54.63 | 2025 | Illuccix |
| Tolmar, INC. | $44.72 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $41.12 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Blue Earth Diagnostics | $39.84 | 2023 | |
| Endo Pharmaceuticals INC. | $30.03 | 2023 | Xiaflex, Aveed |
| 180 Medical, INC. | $25.73 | 2023 | Gentlecath |
| Procept Biorobotics Corporation | $21.49 | 2024 | Aquabeam System |
| Progenics Pharmaceuticals, INC. | $20.60 | 2023 | Pylarify |
| Coloplast Corp | $14.54 | 2025 | |
| Hollister Incorporated | $13.59 | 2023 | Vapro, Infyna Chic, Onli |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Littlefield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.